相关实验视频

Updated: Jul 21, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

免疫治疗方法在异位酸脱酶突变低级质瘤中的免疫治疗方法

Marco Gallus^1,2, Darwin Kwok¹, Senthilnath Lakshmanachetty¹

¹Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.

|July 29, 2023

概括

低级质瘤 (LGGs) 是具有IDH突变的大脑瘤. 目前的治疗方法不足,需要新的疗法,如免疫疗法,这对IDH突变LGG有希望.

科学领域:

神经瘤学神经瘤学
癌症免疫学癌症免疫学
代谢瘤学代谢瘤学

背景情况:

低级质瘤 (LGGs) 是缓慢生长的中枢神经系统 (CNS) 瘤,经常出现发作或神经缺陷.
LGG的一个关键分子特征是异酸脱酶 (IDH) 酶的突变,导致新陈代谢改变和D-2-基酸盐的产生.
尽管在手术,放射治疗和化疗方面取得了进展,但LGG仍然无法治愈,并倾向于恶性转变.

研究的目的:

审查最近针对IDH突变LGG的免疫疗法试验.
讨论在这个患者群体中提高免疫疗法疗效的挑战和未来策略.
探索从疫苗,T细胞和IDH突变抑制剂试验中学到的经验教训.

主要方法:

从免疫疗法试验中对临床前和临床发现的审查.
分析包括瘤异质性和"冷"瘤微环境在内的挑战.
综合了涉及疫苗,T细胞疗法和IDH突变抑制剂的试验数据.

主要成果:

免疫疗法在质瘤中表现出有限的成功,原因是瘤特异性挑战.
最近的免疫疗法试验为IDH突变LGG患者提供了令人鼓舞的初步结果.
IDH突变抑制剂和基于T细胞的疗法是正在积极研究的领域.

结论:

新的治疗方法,特别是免疫疗法,对于治疗不可治愈的IDH突变LGG至关重要.
克服瘤异质性和免疫抑制微环境是成功质瘤免疫治疗的关键.
对疫苗,T细胞疗法和向抑制剂的进一步研究有望改善结果.

关键词:

这是一种IDH-1突变抑制剂.有IDH突变的质瘤.抗原异质性的异质性质瘤疫苗的使用方法用于质瘤的免疫治疗.低强度聚焦超声波低强度聚焦超声波低度结质瘤低度结质瘤

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...